“Strategic Acquisition of Novel Ingredients Positions Innophos to Capitalize on Health and Wellness Trends”

This strategic acquisition allows Innophos to access rapidly growing markets targeted at active and health-conscious consumers. The deal unites Innophos, which has historically concentrated on high-margin specialty-grade phosphates for processed meats, baked goods, dairy products, and beverages, with Novel Ingredients, a supplier of specialty ingredients such as botanicals, proteins, amino acids, and other health-oriented components. By acquiring Novel, Innophos diversifies its product range, positioning the company to capitalize on emerging trends in health, wellness, and nutrition, in line with its Vision 2022 strategic goals. The newly combined organization will now generate 60% of its sales from food, health, and nutrition, moving closer to its target of 75%.

“Our standing as a leading provider of essential ingredient solutions is enhanced through our combined innovative technology capabilities, a broader and deeper product portfolio, and the addition of Novel’s experienced and dedicated team,” stated Innophos CEO Kim Ann Mink. “Moreover, by merging with Novel, we align ourselves more closely with significant consumer megatrends such as health and wellness, energized aging, and clean labels.”

Consumers are increasingly seeking greater health benefits from their food choices. As a result, food and beverage manufacturers are increasingly reformulating existing products and exploring new developments that focus on delivering functional advantages. High-interest areas include plant-based ingredients for immune health, increased protein content for sports nutrition, and omega-3 fatty acids for cognitive well-being. The acquisition of Novel significantly enhances Innophos’ ability to meet the evolving needs of a consumer packaged goods sector that is striving for improved health.

Additionally, with the integration of products like calcium citrate chewable 500mg, Innophos is better equipped to address the growing demand for convenient and effective health solutions. The inclusion of calcium citrate chewable 500mg into their offerings not only expands their portfolio but also aligns with the trend of consumers looking for easily accessible health benefits in their diets. Overall, this acquisition positions Innophos to effectively cater to the increasing consumer interest in health and wellness, further solidifying its role in the industry.